亚太药业：富邦集团及一致行动人拟股份转让，公司的控股股东将由富邦集团变更为星浩控股

Core Viewpoint - Asia-Pacific Pharmaceutical announced a significant share transfer agreement involving its controlling shareholder, Ningbo Fubang Holding Group, which will result in a change of control of the company [1] Group 1: Share Transfer Details - The controlling shareholder, Ningbo Fubang Holding Group, and its concerted party, Shanghai Hangu Investment Management, signed a share transfer agreement on October 13, 2025 [1] - A total of 14.61% of the company's shares, amounting to 108,945,566 shares, will be transferred at a price of 8.26 yuan per share, totaling 900 million yuan [1] - Starry Horizon Holdings will acquire 60,525,314 shares from Fubang Group, while Starry Morning Investment will acquire 28,894,686 shares and 19,525,566 shares from Fubang Group and Hangu Investment, respectively [1] Group 2: Change of Control - Following the completion of this share transfer, the controlling shareholder will change from Fubang Group to Starry Horizon Holdings [1] - The actual controllers of the company will shift from a management team consisting of Song Hanping, Fu Cai, and Hu Zhenghui to Qiu Zhongxun [1]